Evidence map›Paper›PMID 41329039›Full record

ArticleBriefings in bioinformatics2025

Prompt-based multimodal representation learning for drug repurposing.

Jinliang Liu, Kaicheng U, Dhruv Rana, Sophia Meixuan Zhang, Jiahui Yu, Sen Yang, Bo Jin, Xiyue Wang, Zongxin Yang, Hongping Tang and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jinliang LiuSchool of Computer Science and Artificial Intelligence, Zhengzhou University, No. 100 Science Avenue, Zhengzhou, Henan 450001, China.
Kaicheng UTri-Institutional Computational Biology & Medicine, Weill Cornell Medicine, 445 East 69th Street, New York, NY 10021, United States.
Dhruv RanaNYU Department of Psychology, 6 Washington Pl, New York, NY 10003, United States.
Sophia Meixuan ZhangDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States.
Jiahui YuNYU Department of Psychology, 6 Washington Pl, New York, NY 10003, United States.
Sen YangIndependent Researcher.
Bo JinXinda College of Economics and Humanities, Shanghai International Studies University, 999 Dongtan Avenue, Chongming District, Shanghai, China.
Xiyue WangCollege of Biomedical Engineering, Sichuan University, No. 24 South Section 1, Yihuan Road, Chengdu, Sichuan 610065, China.
Zongxin YangDepartment of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Boston, MA 02115, United States.
Hongping TangDepartment of Pathology, Shenzhen Maternity and Child Healthcare Hospital, Women and Children's Medical Center, Southern Medical University, Shenzhen, Guangdong 518042, China.
Junhan ZhaoDepartment of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Boston, MA 02115, United States.ORCID 0000-0002-0316-8365

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748Sanming Project of Medicine in Shenzhen SZSM202211032
6 · The paper itself

Abstract

Drug repurposing significantly reduces development costs and shortens research cycles, making it a critical strategy in drug discovery. An emerging class of drug repurposing approaches applies deep learning to structural data. However, these methods often depend on static representations of molecular and protein structures, which may not fully capture the dynamic character of compound-protein interactions. To address these challenges and enhance the accuracy of compound-protein interaction predictions, we introduce an innovative prompt-based multimodal representation learning framework that dynamically encodes task-specific contextual information for drug repurposing. Specifically, the framework includes a dynamic prompt generation module that adaptively creates receptor-specific prompts and a prompt calibration module for effective multimodal feature integration and optimization. When applied to identifying FDA-approved drug candidates targeting G-protein-coupled receptors, our method achieved a 7.4% improvement in mean absolute error compared with state-of-the-art methods, with up to a 25.1% improvement for specific target-of-interest. By demonstrating potential in repurposing non-opioid treatments without the risk of addiction for safe pain management, our method has the capacity to advance drug discovery and meet a wide range of therapeutic needs.

Indexed as

Deep LearningDrug RepositioningDrug DiscoveryHumansMachine LearningReceptors, G-Protein-CoupledReceptors, G-Protein-Coupleddrug repurposingmultimodalityprompt learningrepresentation learning

Identifiers

PMID41329039
PMCPMC12670639

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.